Skip to content

Inhalational versus intravenously administered dexmedetomidine for blunting hemodynamic responses to laryngoscopy and intubation: a randomized double blind comparative study

Clinical comparison of nebulised versus intravenously administered dexmedetomidine for obtunding hemodynainic responses to laryngoscopy and intubation: a randomized double blind comparative study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058557
Enrollment
60
Registered
2023-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nebulised versus Intravenously administered dexmedetomidine: 1 mcg/kg dexmedetomidine diluted to total volume of 5ml with normal saline 30 mins prior to induction of general anaesthesia

Sponsors

MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective surgeries under general anaesthesia Patients of either sex having age 18-55years Body weight 50 to 70 kgs American society of anaesthesiologists (ASA) physical status I – II Patient’s written and informed consent

Exclusion criteria

Exclusion criteria: Patient refusal for the anaesthetic technique. Patients having mouth opening Patient with severe renal, hepatic, respiratory and cardiac disease. Any bleeding disorder or patient on anticoagulants History of allergy to study drug Patient belonging to ASA CLASS III, IV & V Patients on any sedatives, antipsychotics, antidepressants, anxiolytics or anticonvulsants and betablockers. Patient with any nasal pathology like nasal ulcer, nasal polyp, nasal septum deviation. Patients with difficult airway like cervical spine instability, facial fractures, partially obstructing laryngeal lesions (e.g., papilloma), craniofacial abnormalities, and temporo mandibular joint ankylosis. Patient coming for emergency surgery Pregnant patients H/O Covid infection during last 3 months.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be to compare intravenous dexmedetomidine with nebulised dexmedetomidine as premedication for attenuation of laryngoscopic and intubation response.Timepoint: Vitals will be recorded on starting the study drugs and after every 5 minutes interval till the endotracheal tube is inserted. Also, vitals will be recorded immediately after intubation, 1,3 and 5 minutes after intubation thereafter every 5 minutes up to 30 minutes after insertion of endotracheal tube than at extubation.

Secondary

MeasureTime frame
The secondary outcome of the study will be to study and compare the sedation score and to study and compare the complications encountered with the two routesTimepoint: Sedation score will be calculated at 20 mins after giving drug and any complications will be noted during whole procedure.

Countries

India

Contacts

Public ContactRajkumar Saraswat

MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL

dr.akshita.singla@gmail.com8558084975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026